Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, announced a global out-license agreement with AstraZeneca...
Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, announced that, effective on April 1, 2022,...
Evergreen Nephrology is announcing a joint venture with Colorado Kidney Care, a single specialty nephrology practice caring for patients in the greater Denver Metropolitan...
Lytix Biopharma AS, a clinical-stage company with an in situ vaccination technology platform targeting cancer indications, notes that the first patient has been dosed...
AIkido Pharma Inc. announced that the Company has secured an early equity interest in privately-held Yanka Industries, Inc., doing business as MasterClass . MasterClass...
